Join the Contact Dermatitis group to help and get support from people like you.
Contact Dermatitis News
Related terms: Allergic Dermatitis, Dermatitis, Allergic, Dermatitis, Contact
Lebrikizumab Efficacious, Safe for Patients With Skin of Color, Eczema
WEDNESDAY, Aug. 13, 2025 – For patients with skin of color and atopic dermatitis (AD), lebrikizumab is efficacious and safe, according to a study published online July 15 in the American Journal of...
Novel Treatments Recommended for Management of Atopic Dermatitis in Adults
FRIDAY, July 25, 2025 – In an update to the guidelines for managing atopic dermatitis in adults, four new treatment recommendations are presented. The focused update was published online July 16 in...
FDA Approves First Cream for Treating Chronic Hand Eczema, Anzupgo
THURSDAY, July 24, 2025 — The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic hand eczema (CHE). CHE is common condition ma...
High Dietary Inflammatory Index Tied to Increased Prevalence of Eczema
TUESDAY, July 15, 2025 – A high dietary inflammatory index (DII), which quantifies the inflammatory potential of diet, is associated with increased prevalence of atopic dermatitis (AD), according to...
Atopic Dermatitis May Be Linked to Increased Risk for CKD
TUESDAY, July 15, 2025 – Atopic dermatitis (AD) was associated with an increased risk for chronic kidney disease (CKD) in an Asian population, according to a study published online July 10 in the...
Prevalence, Incidence of Eczema Increase With Severity of Alopecia Areata
MONDAY, July 14, 2025 – Patients with higher-severity alopecia areata (AA) have a higher prevalence and incidence of comorbid atopic dermatitis (AD), according to a study published online June 26 in...
Early Dog Exposure May Modify Genetic Effect on Atopic Eczema Risk
MONDAY, June 9, 2025 – Early-life dog exposure may modify the genetic effect of the single nucleotide variant rs10214237 on atopic eczema (AE) via IL7R, according to a study published online June 4...
Fido Might Protect Your Baby Against Eczema
THURSDAY, June 5, 2025 — Having a family dog might decrease a baby’s risk of developing eczema later in childhood, a new evidence review says. Specifically, exposure to canines appears to influence a ...
AAP Updates Guidelines for Pediatric Atopic Dermatitis Management
MONDAY, May 19, 2025 – In a clinical report published online May 19 in Pediatrics, the American Academy of Pediatrics presents updated guidance for the treatment of children with atopic dermatitis ...
Global Burden of Atopic Dermatitis in Older Adults Is Considerable
WEDNESDAY, May 7, 2025 – The global burden of atopic dermatitis (AD) in older adults is considerable and is expected to continue increasing to 2050, according to a study published online April 1 in...
Early-Onset Pediatric Atopic Dermatitis Tied to Higher Risk for Uveitis
WEDNESDAY, April 23, 2025 – Children with early-onset atopic dermatitis (AD) have an elevated risk for pediatric uveitis, according to a study published online April 3 in JAMA Ophthalmology. Yung-Yu ...
Roflumilast Cream 0.05 Percent Safe, Effective in Young Children With Eczema
FRIDAY, March 14, 2025 – Once-daily roflumilast cream 0.05 percent is safe and effective for atopic dermatitis (AD) in patients ages 2 to 5 years, according to a study published online Feb. 20 in P...
AAD: Maintenance of Low Eczema Activity Seen After About 80 Days Off Tapinarof
FRIDAY, March 14, 2025 – Patients with atopic dermatitis (AD) who achieve completely clear skin with tapinarof (Vtama) cream maintain low disease activity after about 80 days off treatment,...
Early Childhood Stressful Life Events Linked to Increased Eczema Activity
WEDNESDAY, Feb. 5, 2025 – For children with atopic dermatitis (AD), early childhood stressful life events are associated with an increased risk for disease activity, according to a study published...
Study IDs Signs of Topical Steroid Withdrawal in Atopic Dermatitis
WEDNESDAY, Jan. 22, 2025 – Self-reported manifestations of topical steroid withdrawal (TSW) in atopic dermatitis (AD) include erythema, desquamation, dryness, and oozing affecting the face, neck,...
Further information
Related condition support groups
Related drug support groups
prednisone, methylprednisolone, clobetasol, Dupixent, fluocinonide, dexamethasone, desonide, halobetasol, dupilumab